Close Menu
    Facebook LinkedIn YouTube WhatsApp X (Twitter) Pinterest
    Trending
    • Tallahassee property managers accused of spending client funds on gambling and travel
    • Two Lost ‘Doctor Who’ Episodes Found Intact in Waterlogged Collection
    • Personalized Restaurant Ranking with a Two-Tower Embedding Variant
    • Skydream space-age travel trailer makes camp at the push of a button
    • Vilnius-based WhiteBridge AI raises €2.6 million for its AI-powered people research engine
    • What to Do in Vegas If You’re Here for Business (2026)
    • Lawmakers introduce bipartisan POINTS Act targeting gambling addiction treatment funding
    • Today’s NYT Connections Hints, Answers for March 14 #1007
    Facebook LinkedIn WhatsApp
    Times FeaturedTimes Featured
    Saturday, March 14
    • Home
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    • More
      • AI
      • Robotics
      • Industries
      • Global
    Times FeaturedTimes Featured
    Home»Tech Innovation»A new study confirms EBV is a direct trigger for lupus.
    Tech Innovation

    A new study confirms EBV is a direct trigger for lupus.

    Editor Times FeaturedBy Editor Times FeaturedNovember 21, 2025No Comments6 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email WhatsApp Copy Link


    Scientists have discovered the clearest proof but that Epstein-Barr virus (EBV) – which practically all of us carry for all times – is immediately chargeable for hijacking our immune system’s cells to trigger lupus, a continual illness that impacts as much as 1,000,000 People.

    “That is the one most impactful discovering to emerge from my lab in my complete profession,” stated senior creator William Robinson, MD, Chief of the Division of Immunology and Rheumatology at Stanford Division of Drugs. “We predict it applies to 100% of lupus instances.”

    Robinson and his group at Stanford Drugs uncovered a very sneaky mechanism that EBV possesses, which primarily hijacks the physique’s defences to modify sides and mount an assault on the immune system. It is estimated that 90-95%, of US adults carry EBV, which is transmitted in saliva – and even in case you’re asymptomatic, you are caught with this bug for all times.

    “Virtually the one strategy to not get EBV is to reside in a bubble,” Robinson stated. “In case you’ve lived a traditional life,” the percentages are practically 20 to 1 you’ve obtained it.

    On a molecular degree, EBV is a part of the household of viruses that features chickenpox and herpes, in a position to dump its genetic materials into the nuclei of cells it infects, the place it could actually conceal out of sight and undetected by the immune system. Usually the virus stays dormant, however beneath some circumstances it reactivates and takes over the cell’s capabilities, replicating and spreading to different cells and hosts by way of saliva.

    A cell kind EBV likes to cover out in probably the most is the B cell, a white blood cell that has two key roles within the immune system. First, B cells make antibodies – proteins that acknowledge and latch onto invading pathogens – and, second, they act as antigen-presenting cells, that means they present items of these invasive microbes on their floor to alert and activate different immune cells. This helps intensify the immune system’s response.

    Utilizing an ultra-sensitive sequencing know-how developed at Stanford, in addition to bioinformatics and cell-culture experimentation, the scientists found that in wholesome, EBV-positive individuals, of the billions of B cells all of us have, fewer than one in 10,000 carry the virus. However in individuals with lupus erythematosus (lupus), it is extra like one in 400 – or a 25-fold improve.

    Whereas the virus spends most of its existence dormant within the cell, it could actually stir and drive the cell to make a specific viral protein often called EBNA2. Right here, the researchers demonstrated how this protein acts as a change (a transcription issue), turning on genes within the B cell that had till that second been inactive. Sadly, a few these genes present the blueprint for added transcription elements, which then change on pro-inflammatory genes.

    “In our research, we found that Epstein-Barr virus, or EBV, infects and reprograms these similar autoreactive B cells,” stated Robinson. “As soon as contaminated, the cells now not behave usually, they turn out to be what we name ‘driver’ cells, that means they ship persistent inflammatory indicators that activate, maintain and amplify the autoimmune response. That course of seems to be on the coronary heart of lupus.”

    This cascade of genetic modifications in the end results in the contaminated B cells going into overdrive and activating helper T cells. These T cells then recruit many extra immune cells that then assault the physique’s personal nuclear materials, creating the widespread autoimmune response seen in lupus. At this stage, even uninfected B cells will be a part of the combat and set off the inflammatory response.

    “For many years, scientists suspected EBV was related to lupus, however the proof was all the time oblique,” Robinson stated. “This was the primary time we may see that the virus itself was contained in the disease-driving cells, reprogramming them into pro-inflammatory B cells that might clarify how lupus begins.”

    As a result of practically each single certainly one of our cells has a nucleus, antinuclear antibodies can assault organs and tissues all through the physique, main to wreck within the pores and skin, kidneys, joints, coronary heart and nervous system. Lupus overwhelmingly impacts ladies – we nonetheless do not know why – and whereas many individuals hold lupus in verify by remedy, about 5% of victims expertise life-threatening problems.

    The findings additionally elevate the chance that the identical EBV-driven mechanism may very well be driving different autoimmune issues we do not absolutely perceive. Earlier analysis has hinted at EBV involvement in multiple sclerosis, rheumatoid arthritis and Crohn’s disease, and EBNA2 exercise has been detected within the immune cells of individuals with these circumstances.

    Within the US, it is estimated that round 70 individuals in 100,000 develop lupus – which is clearly a lot decrease than People harboring EBV-infected cells. The researchers hypothesize that maybe solely sure EBV strains are in a position to flip B cells into the antigen-presenting cells that go on to recruit antinuclear B cells. Genetic variations in immune regulation might also play a job in how simple a job the virus has in hijacking and recruiting cells.

    “We predict two issues need to occur,” Robinson defined. “First, an individual will need to have these autoreactive B cells – those able to focusing on their very own tissues. Second, EBV should infect these particular cells, not simply the traditional ones.

    “We’re additionally learning whether or not sure strains of EBV usually tend to set off autoimmunity,” he added. “It could be that most individuals are contaminated with innocent variations of the virus, however a number of encounter strains that may reprogram immune cells in a harmful method, particularly if their immune system is genetically extra weak.”

    The unhealthy information is there’s nonetheless no strategy to do away with EBV as soon as an infection has taken place, regardless that researchers are engaged on creating a vaccine that might cease transmission – nevertheless, it’d must be administered in infancy, on condition that odds of publicity throughout childhood and teenage years are extremely excessive.

    Robinson and colleagues have now based EBVio Inc, an organization investigating a lupus remedy often called ultradeep B-cell depletion. It primarily flushes out circulating B cells, which over time are changed by new virus-free cells made within the bone marrow.

    “For the primary time, we’ve a transparent organic rationalization of how Epstein-Barr virus can result in lupus,” Robinson stated. “That understanding may utterly change how we strategy prevention and remedy. There’s already proof that therapies which deeply deplete B cells – primarily wiping out the contaminated and autoreactive ones – can ship lupus into long-term remission, even with out ongoing remedy. Our lab is investigating whether or not that remission occurs as a result of these EBV-infected ‘driver’ cells are being eradicated. In that case, that might transfer us nearer to potential cures.”

    This groundbreaking analysis is a turning level in our understanding lupus, a illness whose roots have been mysterious for many years, and opens the door to creating new prevention and remedy methods – for each EBV and lupus.

    The research was revealed within the journal Science Translational Medicine.

    Supply: Stanford Medicine





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Editor Times Featured
    • Website

    Related Posts

    Skydream space-age travel trailer makes camp at the push of a button

    March 14, 2026

    New lithium battery dendrite strength revealed

    March 13, 2026

    the first Neue Klasse EV

    March 13, 2026

    Outzac Pico Pump: Compact inflatable gear solution

    March 13, 2026

    Rivian R2 SUV pricing revealed, starts at $45,000

    March 13, 2026

    Jiffy 75 split ergonomic keyboard reduces typing strain

    March 13, 2026

    Comments are closed.

    Editors Picks

    Tallahassee property managers accused of spending client funds on gambling and travel

    March 14, 2026

    Two Lost ‘Doctor Who’ Episodes Found Intact in Waterlogged Collection

    March 14, 2026

    Personalized Restaurant Ranking with a Two-Tower Embedding Variant

    March 14, 2026

    Skydream space-age travel trailer makes camp at the push of a button

    March 14, 2026
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    About Us
    About Us

    Welcome to Times Featured, an AI-driven entrepreneurship growth engine that is transforming the future of work, bridging the digital divide and encouraging younger community inclusion in the 4th Industrial Revolution, and nurturing new market leaders.

    Empowering the growth of profiles, leaders, entrepreneurs businesses, and startups on international landscape.

    Asia-Middle East-Europe-North America-Australia-Africa

    Facebook LinkedIn WhatsApp
    Featured Picks

    Sam Altman Says the GPT-5 Haters Got It All Wrong

    October 4, 2025

    Tried Promptchan AI Sexting for 1 Month: My Experience

    August 15, 2025

    ‘Landman’ Season 2: When Episode 2 Hits Paramount Plus

    November 23, 2025
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    Copyright © 2024 Timesfeatured.com IP Limited. All Rights.
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us

    Type above and press Enter to search. Press Esc to cancel.